Quarterly report pursuant to Section 13 or 15(d)

Stock Based Option Compensation and Restricted Stock Compensation

v3.10.0.1
Stock Based Option Compensation and Restricted Stock Compensation
6 Months Ended
Jun. 30, 2018
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock Based Option Compensation and Restricted Stock Compensation
(6)
Stock Based Option Compensation and Restricted Stock Compensation
 
For the three and six months ended June 30, 2018, we recognized stock-based option compensation expense of $2,673,000 and $4,573,000, respectively. For the three and six months ended June 30, 2017, we recognized stock-based option compensation expense of $1,243,000 and $2,735,000, respectively.
 
The following table summarizes stock-based option compensation for the three and six months ended June 30, 2018 and 2017:
 
 
 
Three months ended

June 30,
 
 
Six months ended

June 30,
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Research and development
 
$
900,000
 
 
$
368,000
 
 
$
1,744,000
 
 
$
724,000
 
General and administrative
 
 
1,773,000
 
 
 
875,000
 
 
 
2,829,000
 
 
 
2,011,000
 
Stock-based option compensation expense included in operating expense
 
$
2,673,000
 
 
$
1,243,000
 
 
$
4,573,000
 
 
$
2,735,000
 
 
For the three and six months ended June 30, 2018, we granted 224,800 and 869,800 stock options, respectively, and for the three and six months ended June 30, 2017 we granted 185,000 and 185,000 stock options, respectively.
 
For the three and six months ended June 30, 2018, the fair value of options was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions:
 
For the three months ended June 30, 2018, the fair value of options was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%; volatility of 109%; risk-free interest rate of 2.65%; and expected lives of 5.0 years. The weighted average fair value of options granted was $12.87 per share. The weighted average grant date fair value is $12.87 and the weighted average exercise price is $16.27.
 
For the six months ended June 30, 2018, the fair value of options was estimated at the date of grant using the Black-Scholes option pricing model with the following weighted average assumptions: dividend yield of 0%; volatility of 109%; risk-free interest rate of 2.44%; and expected lives of 5.0 years. The weighted average fair value of options granted was $11.36 per share. The weighted average grant date fair value is $11.36 and the weighted average exercise price is $14.38.
 
For the three and six months ended June 30, 2018, we recognized restricted common stock compensation expense of $172,000 and $344,000, respectively. For the three and six months ended June 30, 2017, we recognized restricted stock compensation expense of $324,000 and $686,000, respectively.
 
The following table summarizes restricted common stock compensation expense for the three and six months ended June 30, 2018 and 2017:
 
 
 
Three months ended

June 30,
 
 
Six months ended

June 30,
 
 
 
2018
 
 
2017
 
 
2018
 
 
2017
 
Research and development
 
$
-
 
 
$
-
 
 
$
-
 
 
$
-
 
General and administrative
 
 
172,000
 
 
 
324,000
 
 
 
344,000
 
 
 
686,000
 
Restricted stock compensation expense included in operating expense
 
$
172,000
 
 
$
324,000
 
 
$
344,000
 
 
$
686,000
 
 
For the three and six months ended June 30, 2018 and June 30, 2017 no common stock was granted to directors or employees.